English Korean Chinese
ホーム > 市場調査レポート > 医薬品 > がん > 世界の癌治療薬市場:市場予測(〜2013年)
カテゴリ
医薬品 (4955)
OTC (153)
がん (943)
ドラッグデリバリー (185)
ワクチン (182)
感染症 (351)
規制環境 (130)
後発医薬品 (134)
骨疾患 (37)
処方薬 (157)
神経疾患 (174)
精神疾患 (88)
製薬企業関連 (531)
創薬 (1523)
糖尿病 (192)
動物用医薬 (17)
肥満症 (44)
市場調査レポート

世界の癌治療薬市場:市場予測(〜2013年)

The Oncology Market Forecast to 2013

発行 Cutting Edge Information
出版日 2008年07月 商品コード 69891
ページ情報 英文 400 Pages
価格
US$ 9,995 換算 ¥ 806,496 (税抜) PDF by E-mail (Single User License)
US$ 20,995 換算 ¥ 1,694,086 (税抜) PDF by E-mail (Multi User License)


原文目次

Abstract

Give Your Team Access to the Most Comprehensive Oncology Forecast Ever Created

Cutting Edge Information' s new report, "Oncology Market Forecast to 2013," explores the fiercely competitive oncology market in a way that no other available forecast can match.

Our experienced analysts have reviewed thousands of historical and forecasted data points to provide the most comprehensive oncology market outlook ever - pulling together data from our own proprietary PharmaEdge databases, along with hundreds of additional public and private databases worldwide.

Give your brand team all the oncology data it needs to make critical product decisions!

Key Questions This Report Will Answer:

  • Which drugs will make the most money in the next five years?
  • Which drug classes are poised for exponential growth?
  • Whose portfolio will allow them to jump out in front of the oncology market?

Table of Contents

Chapter 1: Analysis of Cancer Drugs by Classes (130+ Drug Profiles)

  • - BRAND INFORMATION
    • Brand and generic name
    • Drug class
    • Delivery mechanism
    • Line of treatment
  • - SALES DATA
    • Historical/current sales
    • Forecasted sales
  • - APPROVED INDICATIONS
  • - CURRENT PRODUCT DEVELOPMENT PHASES
  • - COMPETITIVE AND STRATEGIC POSITIONING
  • - MARKET OPPORTUNITIES AND BRAND GROWTH
  • - PATENT, GENERIC AND LITIGATION INFORMATION

Chapter 2: Oncology Indications

  • - ANALYSIS OF MARKETS FOR DIFFERENT CANCER TYPES
    • Current sales, major drugs and important companies
    • Forecasted sales and assessment of future drugs and market players
    • Pipeline development status
    • Major market events, changes in treatments, patent expirations, etc.

Chapter 3: Top Companies' Oncology Portfolios

  • - ANALYSIS OF MAJOR ONCOLOGY COMPANIES
    • Current sales, major drugs and important companies
    • Forecasted sales and assessment of future drugs and market players
    • Pipeline development status
Back to Top